Binding	NN	B-NP	O	Other	###	1	Binding	Binding	NN	NN	_	2	compound	_	_
characteristics	NNS	I-NP	O	Other	###	2	characteristics	characteristics	NNS	NNS	_	0	root	_	_
of	IN	B-PP	O	Other	###	3	of	of	IN	IN	_	6	case	_	_
the	DT	B-NP	O	Other	###	4	the	the	DT	DT	_	6	det	_	_
glucocorticoid	NN	I-NP	B-protein	B-Protein	###	5	glucocorticoid	glucocorticoid	NN	NN	_	6	compound	_	_
receptor	NN	I-NP	I-protein	I-Protein	###	6	receptor	receptor	NN	NN	_	2	nmod	_	_
in	IN	B-PP	O	Other	###	7	in	in	IN	IN	_	10	case	_	_
peripheral	JJ	B-NP	B-cell_type	Other	###	8	peripheral	peripheral	JJ	JJ	_	10	amod	_	_
blood	NN	I-NP	I-cell_type	Other	###	9	blood	blood	NN	NN	_	10	compound	_	_
lymphocytes	NNS	I-NP	I-cell_type	Other	###	10	lymphocytes	lymphocytes	NNS	NNS	_	2	nmod	_	_
in	IN	B-PP	O	Other	###	11	in	in	IN	IN	_	13	case	_	_
multiple	JJ	B-NP	O	Other	###	12	multiple	multiple	JJ	JJ	_	13	amod	_	_
sclerosis	NN	I-NP	O	Other	###	13	sclerosis	sclerosis	NN	NN	_	10	nmod	_	_
.	.	O	O	Other	###	14	.	.	.	.	_	2	punct	_	_

Although	IN	B-SBAR	O	Other	###	1	Although	Although	IN	IN	_	11	mark	_	_
the	DT	B-NP	O	Other	###	2	the	the	DT	DT	_	4	det	_	_
exact	JJ	I-NP	O	Other	###	3	exact	exact	JJ	JJ	_	4	amod	_	_
etiology	NN	I-NP	O	Other	###	4	etiology	etiology	NN	NN	_	11	nsubj	_	_
of	IN	B-PP	O	Other	###	5	of	of	IN	IN	_	7	case	_	_
multiple	JJ	B-NP	O	Other	###	6	multiple	multiple	JJ	JJ	_	7	amod	_	_
sclerosis	NN	I-NP	O	Other	###	7	sclerosis	sclerosis	NN	NN	_	4	nmod	_	_
(	(	O	O	Other	###	8	(	(	(	(	_	9	punct	_	_
MS	NN	B-NP	O	Other	###	9	MS	MS	NN	NN	_	7	appos	_	_
)	)	O	O	Other	###	10	)	)	)	)	_	9	punct	_	_
remains	VBZ	B-VP	O	Other	###	11	remains	remains	VBZ	VBZ	_	17	advcl	_	_
unresolved	JJ	B-NP	O	Other	###	12	unresolved	unresolved	JJ	JJ	_	11	xcomp	_	_
,	,	I-NP	O	Other	###	13	,	,	,	,	_	17	punct	_	_
immune	JJ	I-NP	O	Other	###	14	immune	immune	JJ	JJ	_	15	amod	_	_
reactions	NNS	I-NP	O	Other	###	15	reactions	reactions	NNS	NNS	_	17	nsubjpass	_	_
are	VBP	B-VP	O	Other	###	16	are	are	VBP	VBP	_	17	auxpass	_	_
believed	VBN	I-VP	O	Other	###	17	believed	believed	VBN	VBN	_	0	root	_	_
to	TO	I-VP	O	Other	###	18	to	to	TO	TO	_	23	mark	_	_
be	VB	I-VP	O	Other	###	19	be	be	VB	VB	_	23	cop	_	_
the	DT	B-NP	O	Other	###	20	the	the	DT	DT	_	23	det	_	_
central	JJ	I-NP	O	Other	###	21	central	central	JJ	JJ	_	23	amod	_	_
pathogenic	JJ	I-NP	O	Other	###	22	pathogenic	pathogenic	JJ	JJ	_	23	amod	_	_
mechanisms	NNS	I-NP	O	Other	###	23	mechanisms	mechanisms	NNS	NNS	_	17	xcomp	_	_
.	.	O	O	Other	###	24	.	.	.	.	_	17	punct	_	_

Endogenous	JJ	B-NP	O	Other	###	1	Endogenous	Endogenous	JJ	JJ	_	5	amod	_	_
and	CC	I-NP	O	Other	###	2	and	and	CC	CC	_	1	cc	_	_
therapeutic	JJ	I-NP	O	Other	###	3	therapeutic	therapeutic	JJ	JJ	_	1	conj	_	_
steroid	NN	I-NP	O	Other	###	4	steroid	steroid	NN	NN	_	5	compound	_	_
hormones	NNS	I-NP	O	Other	###	5	hormones	hormones	NNS	NNS	_	6	nsubj	_	_
affect	VBP	B-VP	O	Other	###	6	affect	affect	VBP	VBP	_	0	root	_	_
the	DT	B-NP	O	Other	###	7	the	the	DT	DT	_	9	det	_	_
immune	JJ	I-NP	O	Other	###	8	immune	immune	JJ	JJ	_	9	amod	_	_
system	NN	I-NP	O	Other	###	9	system	system	NN	NN	_	6	dobj	_	_
,	,	O	O	Other	###	10	,	,	,	,	_	6	punct	_	_
and	CC	O	O	Other	###	11	and	and	CC	CC	_	6	cc	_	_
inflammatory	JJ	B-NP	O	Other	###	12	inflammatory	inflammatory	JJ	JJ	_	13	amod	_	_
diseases	NNS	I-NP	O	Other	###	13	diseases	diseases	NNS	NNS	_	15	nsubjpass	_	_
are	VBP	B-VP	O	Other	###	14	are	are	VBP	VBP	_	15	auxpass	_	_
associated	VBN	I-VP	O	Other	###	15	associated	associated	VBN	VBN	_	6	conj	_	_
with	IN	B-PP	O	Other	###	16	with	with	IN	IN	_	17	case	_	_
activation	NN	B-NP	O	Other	###	17	activation	activation	NN	NN	_	15	nmod	_	_
of	IN	B-PP	O	Other	###	18	of	of	IN	IN	_	21	case	_	_
the	DT	B-NP	O	Other	###	19	the	the	DT	DT	_	21	det	_	_
hypothalamic-pituitary-adrenal	JJ	I-NP	O	Other	###	20	hypothalamic-pituitary-adrenal	hypothalamic-pituitary-adrenal	JJ	JJ	_	21	amod	_	_
axis	NN	I-NP	O	Other	###	21	axis	axis	NN	NN	_	17	nmod	_	_
,	,	O	O	Other	###	22	,	,	,	,	_	15	punct	_	_
providing	VBG	B-VP	O	Other	###	23	providing	providing	VBG	VBG	_	15	xcomp	_	_
evidence	NN	B-NP	O	Other	###	24	evidence	evidence	NN	NN	_	23	dobj	_	_
of	IN	B-PP	O	Other	###	25	of	of	IN	IN	_	28	case	_	_
an	DT	B-NP	O	Other	###	26	an	an	DT	DT	_	28	det	_	_
immune-endocrine	JJ	I-NP	O	Other	###	27	immune-endocrine	immune-endocrine	JJ	JJ	_	28	amod	_	_
interplay	NN	I-NP	O	Other	###	28	interplay	interplay	NN	NN	_	24	nmod	_	_
.	.	O	O	Other	###	29	.	.	.	.	_	6	punct	_	_

Function	NN	B-NP	O	Other	###	1	Function	Function	NN	NN	_	2	compound	_	_
tests	NNS	I-NP	O	Other	###	2	tests	tests	NNS	NNS	_	6	nsubj	_	_
in	IN	B-PP	O	Other	###	3	in	in	IN	IN	_	4	case	_	_
MS	NN	B-NP	O	Other	###	4	MS	MS	NN	NN	_	2	nmod	_	_
have	VBP	B-VP	O	Other	###	5	have	have	VBP	VBP	_	6	aux	_	_
revealed	VBN	I-VP	O	Other	###	6	revealed	revealed	VBN	VBN	_	0	root	_	_
dysregulation	NN	B-NP	O	Other	###	7	dysregulation	dysregulation	NN	NN	_	6	dobj	_	_
of	IN	B-PP	O	Other	###	8	of	of	IN	IN	_	11	case	_	_
the	DT	B-NP	O	Other	###	9	the	the	DT	DT	_	11	det	_	_
hypothalamic-pituitary-adrenal	JJ	I-NP	O	Other	###	10	hypothalamic-pituitary-adrenal	hypothalamic-pituitary-adrenal	JJ	JJ	_	11	amod	_	_
system	NN	I-NP	O	Other	###	11	system	system	NN	NN	_	7	nmod	_	_
in	IN	B-PP	O	Other	###	12	in	in	IN	IN	_	15	case	_	_
a	DT	B-NP	O	Other	###	13	a	a	DT	DT	_	15	det	_	_
substantial	JJ	I-NP	O	Other	###	14	substantial	substantial	JJ	JJ	_	15	amod	_	_
proportion	NN	I-NP	O	Other	###	15	proportion	proportion	NN	NN	_	7	nmod	_	_
of	IN	B-PP	O	Other	###	16	of	of	IN	IN	_	17	case	_	_
patients	NNS	B-NP	O	Other	###	17	patients	patients	NNS	NNS	_	15	nmod	_	_
.	.	O	O	Other	###	18	.	.	.	.	_	6	punct	_	_

We	PRP	B-NP	O	Other	###	1	We	We	PRP	PRP	_	2	nsubj	_	_
characterized	VBD	B-VP	O	Other	###	2	characterized	characterized	VBD	VBD	_	0	root	_	_
glucocorticoid	NN	B-NP	B-protein	B-Protein	###	3	glucocorticoid	glucocorticoid	NN	NN	_	4	compound	_	_
receptor	NN	I-NP	I-protein	I-Protein	###	4	receptor	receptor	NN	NN	_	8	compound	_	_
(	(	O	O	Other	###	5	(	(	(	(	_	6	punct	_	_
GR	NN	B-NP	B-protein	B-Protein	###	6	GR	GR	NN	NN	_	4	appos	_	_
)	)	O	O	Other	###	7	)	)	)	)	_	6	punct	_	_
binding	NN	B-NP	O	Other	###	8	binding	binding	NN	NN	_	2	dobj	_	_
in	IN	B-PP	O	Other	###	9	in	in	IN	IN	_	12	case	_	_
peripheral	JJ	B-NP	B-cell_type	Other	###	10	peripheral	peripheral	JJ	JJ	_	12	amod	_	_
blood	NN	I-NP	I-cell_type	Other	###	11	blood	blood	NN	NN	_	12	compound	_	_
lymphocytes	NNS	I-NP	I-cell_type	Other	###	12	lymphocytes	lymphocytes	NNS	NNS	_	8	nmod	_	_
from	IN	B-PP	O	Other	###	13	from	from	IN	IN	_	16	case	_	_
39	CD	B-NP	O	Other	###	14	39	39	CD	CD	_	16	nummod	_	_
MS	NN	I-NP	O	Other	###	15	MS	MS	NN	NN	_	16	compound	_	_
patients	NNS	I-NP	O	Other	###	16	patients	patients	NNS	NNS	_	12	nmod	_	_
and	CC	O	O	Other	###	17	and	and	CC	CC	_	16	cc	_	_
14	CD	B-NP	O	Other	###	18	14	14	CD	CD	_	19	nummod	_	_
age	NN	I-NP	O	Other	###	19	age	age	NN	NN	_	16	conj	_	_
-	-	O	O	Other	###	20	-	-	-	-	_	16	punct	_	_
and	CC	I-NP	O	Other	###	21	and	and	CC	CC	_	16	cc	_	_
sex-matched	JJ	I-NP	O	Other	###	22	sex-matched	sex-matched	JJ	JJ	_	23	amod	_	_
controls	NNS	I-NP	O	Other	###	23	controls	controls	NNS	NNS	_	16	conj	_	_
with	IN	B-PP	O	Other	###	24	with	with	IN	IN	_	25	case	_	_
respect	NN	B-NP	O	Other	###	25	respect	respect	NN	NN	_	2	nmod	_	_
to	TO	B-PP	O	Other	###	26	to	to	TO	TO	_	28	case	_	_
dissociation	NN	B-NP	O	Other	###	27	dissociation	dissociation	NN	NN	_	28	compound	_	_
constant	NN	I-NP	O	Other	###	28	constant	constant	NN	NN	_	25	nmod	_	_
and	CC	O	O	Other	###	29	and	and	CC	CC	_	28	cc	_	_
binding	NN	B-NP	O	Other	###	30	binding	binding	NN	NN	_	31	compound	_	_
capacity	NN	I-NP	O	Other	###	31	capacity	capacity	NN	NN	_	28	conj	_	_
,	,	O	O	Other	###	32	,	,	,	,	_	2	punct	_	_
using	VBG	B-VP	O	Other	###	33	using	using	VBG	VBG	_	2	advcl	_	_
a	DT	B-NP	O	Other	###	34	a	a	DT	DT	_	37	det	_	_
whole-cell	JJ	I-NP	O	Other	###	35	whole-cell	whole-cell	JJ	JJ	_	37	amod	_	_
binding	NN	I-NP	O	Other	###	36	binding	binding	NN	NN	_	37	compound	_	_
assay	NN	I-NP	O	Other	###	37	assay	assay	NN	NN	_	33	dobj	_	_
with	IN	B-PP	O	Other	###	38	with	with	IN	IN	_	39	mark	_	_
[	(	B-NP	O	Other	###	39	[	[	(	(	_	37	acl	_	_
3H	NN	I-NP	O	Other	###	40	3H	3H	NN	NN	_	41	nsubj	_	_
]	)	I-NP	O	Other	###	41	]	]	)	)	_	33	ccomp	_	_
dexamethasone	NN	I-NP	O	Other	###	42	dexamethasone	dexamethasone	NN	NN	_	41	dobj	_	_
as	IN	B-PP	O	Other	###	43	as	as	IN	IN	_	45	case	_	_
the	DT	B-NP	O	Other	###	44	the	the	DT	DT	_	45	det	_	_
ligand	NN	I-NP	O	Other	###	45	ligand	ligand	NN	NN	_	41	nmod	_	_
.	.	O	O	Other	###	46	.	.	.	.	_	2	punct	_	_

GR	NN	B-NP	B-protein	B-Protein	###	1	GR	GR	NN	NN	_	3	compound	_	_
binding	NN	I-NP	O	Other	###	2	binding	binding	NN	NN	_	3	compound	_	_
parameters	NNS	I-NP	O	Other	###	3	parameters	parameters	NNS	NNS	_	6	nsubj	_	_
did	VBD	B-VP	O	Other	###	4	did	did	VBD	VBD	_	6	aux	_	_
not	RB	I-VP	O	Other	###	5	not	not	RB	RB	_	6	neg	_	_
differ	VB	I-VP	O	Other	###	6	differ	differ	VB	VB	_	0	root	_	_
significantly	RB	B-ADVP	O	Other	###	7	significantly	significantly	RB	RB	_	6	advmod	_	_
between	IN	B-PP	O	Other	###	8	between	between	IN	IN	_	9	case	_	_
patients	NNS	B-NP	O	Other	###	9	patients	patients	NNS	NNS	_	6	nmod	_	_
(	(	O	O	Other	###	10	(	(	(	(	_	11	punct	_	_
Kd	NN	B-NP	O	Other	###	11	Kd	Kd	NN	NN	_	9	dep	_	_
8.98	CD	I-NP	O	Other	###	12	8.98	8.98	CD	CD	_	11	nummod	_	_
+/-	SYM	I-NP	O	Other	###	13	+/-	+/-	SYM	SYM	_	11	cc	_	_
1.07	CD	I-NP	O	Other	###	14	1.07	1.07	CD	CD	_	15	nummod	_	_
nM	NN	I-NP	O	Other	###	15	nM	nM	NN	NN	_	11	conj	_	_
,	,	O	O	Other	###	16	,	,	,	,	_	11	punct	_	_
Bmax	NN	B-NP	O	Other	###	17	Bmax	Bmax	NN	NN	_	11	appos	_	_
183	CD	I-NP	O	Other	###	18	183	183	CD	CD	_	17	nummod	_	_
+/-	SYM	I-NP	O	Other	###	19	+/-	+/-	SYM	SYM	_	17	cc	_	_
29.8	CD	I-NP	O	Other	###	20	29.8	29.8	CD	CD	_	21	nummod	_	_
fmol	NN	I-NP	O	Other	###	21	fmol	fmol	NN	NN	_	17	conj	_	_
/	/	O	O	Other	###	22	/	/	/	/	_	23	punct	_	_
mg	NN	I-NP	O	Other	###	23	mg	mg	NN	NN	_	17	conj	_	_
)	)	O	O	Other	###	24	)	)	)	)	_	11	punct	_	_
and	CC	O	O	Other	###	25	and	and	CC	CC	_	9	cc	_	_
controls	NNS	B-NP	O	Other	###	26	controls	controls	NNS	NNS	_	9	conj	_	_
(	(	O	O	Other	###	27	(	(	(	(	_	28	punct	_	_
Kd	NN	B-NP	O	Other	###	28	Kd	Kd	NN	NN	_	26	dep	_	_
9.36	CD	I-NP	O	Other	###	29	9.36	9.36	CD	CD	_	28	nummod	_	_
+/-	CC	I-NP	O	Other	###	30	+/-	+/-	CC	CC	_	28	cc	_	_
1.17	CD	I-NP	O	Other	###	31	1.17	1.17	CD	CD	_	32	nummod	_	_
nM	NN	I-NP	O	Other	###	32	nM	nM	NN	NN	_	28	conj	_	_
,	,	O	O	Other	###	33	,	,	,	,	_	28	punct	_	_
Bmax	NN	B-NP	O	Other	###	34	Bmax	Bmax	NN	NN	_	28	appos	_	_
158	CD	I-NP	O	Other	###	35	158	158	CD	CD	_	34	nummod	_	_
+/-	CC	I-NP	O	Other	###	36	+/-	+/-	CC	CC	_	34	cc	_	_
16	CD	I-NP	O	Other	###	37	16	16	CD	CD	_	38	nummod	_	_
fmol	NN	I-NP	O	Other	###	38	fmol	fmol	NN	NN	_	34	conj	_	_
/	/	O	O	Other	###	39	/	/	/	/	_	40	punct	_	_
mg	NN	I-NP	O	Other	###	40	mg	mg	NN	NN	_	34	conj	_	_
)	)	O	O	Other	###	41	)	)	)	)	_	28	punct	_	_
.	.	O	O	Other	###	42	.	.	.	.	_	6	punct	_	_

No	DT	B-NP	O	Other	###	1	No	No	DT	DT	_	2	neg	_	_
effect	NN	I-NP	O	Other	###	2	effect	effect	NN	NN	_	21	nsubjpass	_	_
of	IN	B-PP	O	Other	###	3	of	of	IN	IN	_	4	case	_	_
age	NN	B-NP	O	Other	###	4	age	age	NN	NN	_	2	nmod	_	_
,	,	O	O	Other	###	5	,	,	,	,	_	4	punct	_	_
sex	NN	B-NP	O	Other	###	6	sex	sex	NN	NN	_	4	conj	_	_
,	,	O	O	Other	###	7	,	,	,	,	_	4	punct	_	_
course	NN	B-NP	O	Other	###	8	course	course	NN	NN	_	4	conj	_	_
,	,	O	O	Other	###	9	,	,	,	,	_	4	punct	_	_
duration	NN	B-NP	O	Other	###	10	duration	duration	NN	NN	_	4	conj	_	_
or	CC	I-NP	O	Other	###	11	or	or	CC	CC	_	4	cc	_	_
severity	NN	I-NP	O	Other	###	12	severity	severity	NN	NN	_	4	conj	_	_
of	IN	B-PP	O	Other	###	13	of	of	IN	IN	_	14	case	_	_
disease	NN	B-NP	O	Other	###	14	disease	disease	NN	NN	_	12	nmod	_	_
,	,	O	O	Other	###	15	,	,	,	,	_	4	punct	_	_
or	CC	O	O	Other	###	16	or	or	CC	CC	_	4	cc	_	_
prior	JJ	B-NP	O	Other	###	17	prior	prior	JJ	JJ	_	19	amod	_	_
steroid	NN	I-NP	O	Other	###	18	steroid	steroid	NN	NN	_	19	compound	_	_
treatments	NNS	I-NP	O	Other	###	19	treatments	treatments	NNS	NNS	_	4	conj	_	_
was	VBD	B-VP	O	Other	###	20	was	was	VBD	VBD	_	21	auxpass	_	_
detected	VBN	I-VP	O	Other	###	21	detected	detected	VBN	VBN	_	0	root	_	_
.	.	O	O	Other	###	22	.	.	.	.	_	21	punct	_	_

GR	NN	B-NP	B-protein	B-Protein	###	1	GR	GR	NN	NN	_	3	compound	_	_
binding	NN	I-NP	O	Other	###	2	binding	binding	NN	NN	_	3	compound	_	_
parameters	NNS	I-NP	O	Other	###	3	parameters	parameters	NNS	NNS	_	5	nsubjpass	_	_
were	VBD	B-VP	O	Other	###	4	were	were	VBD	VBD	_	5	auxpass	_	_
analyzed	VBN	I-VP	O	Other	###	5	analyzed	analyzed	VBN	VBN	_	0	root	_	_
in	IN	B-PP	O	Other	###	6	in	in	IN	IN	_	7	case	_	_
relation	NN	B-NP	O	Other	###	7	relation	relation	NN	NN	_	5	nmod	_	_
to	TO	B-PP	O	Other	###	8	to	to	TO	TO	_	10	case	_	_
the	DT	B-NP	O	Other	###	9	the	the	DT	DT	_	10	det	_	_
results	NNS	I-NP	O	Other	###	10	results	results	NNS	NNS	_	7	nmod	_	_
of	IN	B-PP	O	Other	###	11	of	of	IN	IN	_	14	case	_	_
the	DT	B-NP	O	Other	###	12	the	the	DT	DT	_	14	det	_	_
combined	JJ	I-NP	O	Other	###	13	combined	combined	JJ	JJ	_	14	amod	_	_
dexamethasone	NN	B-NP	O	Other	###	14	dexamethasone	dexamethasone	NN	NN	_	10	nmod	_	_
-	-	O	O	Other	###	15	-	-	-	-	_	14	punct	_	_
CRH	NN	B-NP	B-protein	B-Protein	###	16	CRH	CRH	NN	NN	_	17	compound	_	_
test	NN	I-NP	O	Other	###	17	test	test	NN	NN	_	14	dep	_	_
,	,	O	O	Other	###	18	,	,	,	,	_	14	punct	_	_
which	WDT	B-NP	O	Other	###	19	which	which	WDT	WDT	_	20	nsubj	_	_
reflects	VBZ	B-VP	O	Other	###	20	reflects	reflects	VBZ	VBZ	_	14	acl:relcl	_	_
corticosteroid	NN	B-NP	B-protein	Other	###	21	corticosteroid	corticosteroid	NN	NN	_	23	compound	_	_
receptor	NN	I-NP	I-protein	Other	###	22	receptor	receptor	NN	NN	_	23	compound	_	_
function	NN	I-NP	O	Other	###	23	function	function	NN	NN	_	20	dobj	_	_
at	IN	B-PP	O	Other	###	24	at	at	IN	IN	_	26	case	_	_
the	DT	B-NP	O	Other	###	25	the	the	DT	DT	_	26	det	_	_
hypothalamus	NN	I-NP	O	Other	###	26	hypothalamus	hypothalamus	NN	NN	_	23	nmod	_	_
,	,	O	O	Other	###	27	,	,	,	,	_	23	punct	_	_
in	IN	B-PP	O	Other	###	28	in	in	IN	IN	_	30	case	_	_
30	CD	B-NP	O	Other	###	29	30	30	CD	CD	_	30	nummod	_	_
patients	NNS	I-NP	O	Other	###	30	patients	patients	NNS	NNS	_	23	nmod	_	_
and	CC	O	O	Other	###	31	and	and	CC	CC	_	30	cc	_	_
9	CD	B-NP	O	Other	###	32	9	9	CD	CD	_	33	nummod	_	_
controls	NNS	I-NP	O	Other	###	33	controls	controls	NNS	NNS	_	30	conj	_	_
.	.	O	O	Other	###	34	.	.	.	.	_	5	punct	_	_

While	IN	B-SBAR	O	Other	###	1	While	While	IN	IN	_	3	mark	_	_
controls	NNS	B-NP	O	Other	###	2	controls	controls	NNS	NNS	_	3	nsubj	_	_
showed	VBD	B-VP	O	Other	###	3	showed	showed	VBD	VBD	_	25	advcl	_	_
a	DT	B-NP	O	Other	###	4	a	a	DT	DT	_	6	det	_	_
moderate	JJ	I-NP	O	Other	###	5	moderate	moderate	JJ	JJ	_	6	amod	_	_
correlation	NN	I-NP	O	Other	###	6	correlation	correlation	NN	NN	_	3	dobj	_	_
between	IN	B-PP	O	Other	###	7	between	between	IN	IN	_	9	case	_	_
binding	NN	B-NP	O	Other	###	8	binding	binding	NN	NN	_	9	compound	_	_
affinity	NN	I-NP	O	Other	###	9	affinity	affinity	NN	NN	_	6	nmod	_	_
of	IN	B-PP	O	Other	###	10	of	of	IN	IN	_	12	case	_	_
the	DT	B-NP	O	Other	###	11	the	the	DT	DT	_	12	det	_	_
GR	NN	I-NP	B-protein	B-Protein	###	12	GR	GR	NN	NN	_	9	nmod	_	_
in	IN	B-PP	O	Other	###	13	in	in	IN	IN	_	14	case	_	_
lymphocytes	NNS	B-NP	B-cell_type	Other	###	14	lymphocytes	lymphocytes	NNS	NNS	_	9	nmod	_	_
and	CC	O	O	Other	###	15	and	and	CC	CC	_	9	cc	_	_
regulatory	JJ	B-NP	O	Other	###	16	regulatory	regulatory	JJ	JJ	_	17	amod	_	_
function	NN	I-NP	O	Other	###	17	function	function	NN	NN	_	9	conj	_	_
at	IN	B-PP	O	Other	###	18	at	at	IN	IN	_	21	case	_	_
the	DT	B-NP	O	Other	###	19	the	the	DT	DT	_	21	det	_	_
hypothalamic	JJ	I-NP	O	Other	###	20	hypothalamic	hypothalamic	JJ	JJ	_	21	amod	_	_
level	NN	I-NP	O	Other	###	21	level	level	NN	NN	_	17	nmod	_	_
,	,	O	O	Other	###	22	,	,	,	,	_	25	punct	_	_
the	DT	B-NP	O	Other	###	23	the	the	DT	DT	_	24	det	_	_
patients	NNS	I-NP	O	Other	###	24	patients	patients	NNS	NNS	_	25	nsubj	_	_
did	VBD	B-VP	O	Other	###	25	did	did	VBD	VBD	_	0	root	_	_
not	RB	O	O	Other	###	26	not	not	RB	RB	_	25	neg	_	_
.	.	O	O	Other	###	27	.	.	.	.	_	25	punct	_	_

These	DT	B-NP	O	Other	###	1	These	These	DT	DT	_	2	det	_	_
data	NNS	I-NP	O	Other	###	2	data	data	NNS	NNS	_	3	nsubj	_	_
suggest	VBP	B-VP	O	Other	###	3	suggest	suggest	VBP	VBP	_	0	root	_	_
that	IN	B-SBAR	O	Other	###	4	that	that	IN	IN	_	17	mark	_	_
the	DT	B-NP	O	Other	###	5	the	the	DT	DT	_	7	det	_	_
physiological	JJ	I-NP	O	Other	###	6	physiological	physiological	JJ	JJ	_	7	amod	_	_
relationship	NN	I-NP	O	Other	###	7	relationship	relationship	NN	NN	_	17	nsubjpass	_	_
between	IN	B-PP	O	Other	###	8	between	between	IN	IN	_	9	case	_	_
binding	NN	B-NP	O	Other	###	9	binding	binding	NN	NN	_	7	nmod	_	_
and	CC	I-NP	O	Other	###	10	and	and	CC	CC	_	9	cc	_	_
function	NN	I-NP	O	Other	###	11	function	function	NN	NN	_	9	conj	_	_
of	IN	B-PP	O	Other	###	12	of	of	IN	IN	_	15	case	_	_
the	DT	B-NP	O	Other	###	13	the	the	DT	DT	_	15	det	_	_
glucocorticoid	NN	I-NP	B-protein	B-Protein	###	14	glucocorticoid	glucocorticoid	NN	NN	_	15	compound	_	_
receptor	NN	I-NP	I-protein	I-Protein	###	15	receptor	receptor	NN	NN	_	9	nmod	_	_
is	VBZ	B-VP	O	Other	###	16	is	is	VBZ	VBZ	_	17	auxpass	_	_
disturbed	VBN	I-VP	O	Other	###	17	disturbed	disturbed	VBN	VBN	_	3	ccomp	_	_
in	IN	B-PP	O	Other	###	18	in	in	IN	IN	_	19	case	_	_
MS	NN	B-NP	O	Other	###	19	MS	MS	NN	NN	_	17	nmod	_	_
.	.	O	O	Other	###	20	.	.	.	.	_	3	punct	_	_

